Skip to content

Development of an mHealth Tool (ANíMATE) to Assess Self-management, Self-care and Adherence in People With Obesity

Development of an mHealth Tool (ANíMATE) to Assess Self-management, Self-care and Adherence in People With Obesity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05236881
Acronym
ANíMATE
Enrollment
36
Registered
2022-02-11
Start date
2022-04-20
Completion date
2025-01-31
Last updated
2025-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Obesity, mHealth, mobile application, self-management, self-care, adherence

Brief summary

This trial main purpose is to develop and test an mHealth app aimed at improving self-management, self-care and adherence of people with obesity. The study population are type I or II obese people, aged more than 18 years old, with or without comorbidities, who have a smartphone or tablet compatible with the app (Android version 9.0 or higher) and access to a scale for regular weight monitoring. Control group will follow standard care protocol and patients in the intervention group will also be provided with the app. Follow-up will be done for 16 weeks. Both groups will attend 3 face-to-face visits (baseline, 2 and 4 months).

Interventions

DEVICEANíMATE mobile application

mHealth tool ANíMATE (Adherence, Nutrition, PhysIcal Activity, Motivation, medicAtion, Technology and Empowerment) allows the recording of data related to diet and exercise and feedback on behavior through an intelligent data analysis system.

Sponsors

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Patients over 18 years of age. * People with BMI 30-39.9 kg/m2. * Have a smartphone or tablet compatible with the app (Android version 9.0 or higher) and have sufficient capabilities to use it. * Have access to a scale for regular weight monitoring.

Exclusion criteria

* Presence of serious major comorbidities: High blood pressure treated with \> 3 drugs, diabetes mellitus treated with insulin, dyslipidemia treated with PCSK9 inhibitors, sleep apnea-hypopnea syndrome treated with CPAP, ischemic heart disease or stroke. * Use of pharmacological treatment with influence on weight started in the 6 months prior to study entry. * History of weight loss intervention (diet, exercise) in the 6 months prior to study entry. * History of eating disorder. * History of bariatric surgery. * Use of any other app or treatment to lose weight in the 6 months prior to study entry. * Pregnancy, short-term gestational desire or lactation. * Any other disease or condition that may interfere with compliance with the protocol or completion of the study.

Design outcomes

Primary

MeasureTime frameDescription
%TWL at 4 months4 monthsPercentage of total weight loss (%TWL) at 4 months

Secondary

MeasureTime frameDescription
%TWL at 2 months2 monthsPercentage of total weight loss (%TWL) at 2 months
%EWL at 2 and 4 months2 and 4 monthsPercentage of excess weight loss (%EWL) at 2 and 4 months
BMI change at 2 and 4 monthsBaseline, 2 and 4 monthsChange in body mass index (BMI) (kg/m\^2) from baseline to 2 and 4 months
Waist change at 2 and 4 monthsBaseline, 2 and 4 monthsChange in waist circumference (cm) from baseline to 2 and 4 months
Blood pressure change at 2 and 4 monthsBaseline, 2 and 4 monthsChange in systolic and diastolic blood pressure (mmhg) from baseline to 2 and 4 months
Mediterranean diet adherence change at 4 monthsBaseline and 4 monthsChange in mediterranean diet adherence questionnaire score (0\*-14, \*indicates worse questionnaire results) from baseline to 4 months
IPAQ change at 4 monthsBaseline and 4 monthsChange in International Physical Activity Questionnaire (IPAQ) score (cathegory results: low/inactive\*, moderate or high, \*indicates worse questionnaire results) from baseline to 4 months
HbA1c change at 2 and 4 monthsBaseline, 2 and 4 monthsChange in HbA1c percent from baseline to 2 and 4 months
Adherence to records2 and 4 monthsPercentage of records (weight, diet) at 2 and 4 months
Adherence to recommendations2 and 4 monthsPercentage of recommendations given by the medical team followed at next visit
Adherence to visits2 and 4 monthsPercentage of face-to-face visits attended
Adherence to the app2 months after the end of the studyPercentage of patients who continue using the 2 months app after the end of the study
Quality of life change at 4 monthsBaseline and 4 monthsChange in Short-Form Health Survey SF-36 questionnaire score (0\*-100, \*indicates worse questionnaire results) from baseline to 4 months
Satisfaction with the app4 monthsSatisfaction questionnaire in relation to the use of the app score (0\*-20, \*indicates worse questionnaire results) in the intervention group at the end of the study
ACTA change at 4 monthsBaseline and 4 monthsChange in attitudes towards change in eating disorders (ACTA) questionnaire score (0\*-236, \*indicates worse questionnaire results) from baseline to 4 months

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026